ethyl 3-isopropylisoxazole-5-carboxylate
|
- $210 - $904
- Product name: ethyl 3-isopropylisoxazole-5-carboxylate
- CAS: 2207-47-8
- MF: C9H13NO3
- MW: 183.2
- EINECS:
- MDL Number:MFCD12028403
- Synonyms:ethyl 3-isopropylisoxazole-5-carboxylate;5-isoxazolecarboxylic acid, 3-(1-methylethyl)-, ethyl ester;5-isoxazolecarboxylic acid, 3-(1-methylethyl)-, ethyl este;3-isopropyl-isoxazole-5-carboxylic acid ethyl ester
4 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number7547AD
- Product descriptionEthyl3-isopropylisoxazole-5-carboxylate
- Packaging500mg
- Price$333
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11164002
- Product descriptionEthyl3-isopropylisoxazole-5-carboxylate 97%
- Packaging1g
- Price$320
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11164002
- Product descriptionEthyl3-isopropylisoxazole-5-carboxylate 97%
- Packaging5g
- Price$904
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number040767
- Product descriptionEthyl 3-isopropylisoxazole-5-carboxylate
- Packaging500mg
- Price$210
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 7547AD | Ethyl3-isopropylisoxazole-5-carboxylate | 500mg | $333 | 2021-12-16 | Buy |
| Crysdot | CD11164002 | Ethyl3-isopropylisoxazole-5-carboxylate 97% | 1g | $320 | 2021-12-16 | Buy |
| Crysdot | CD11164002 | Ethyl3-isopropylisoxazole-5-carboxylate 97% | 5g | $904 | 2021-12-16 | Buy |
| Matrix Scientific | 040767 | Ethyl 3-isopropylisoxazole-5-carboxylate | 500mg | $210 | 2021-12-16 | Buy |
Properties
Boiling point :82.2 °C(Press: 2.5 Torr)
Density :1.078±0.06 g/cm3(Predicted)
pka :-3.51±0.50(Predicted)
Density :1.078±0.06 g/cm3(Predicted)
pka :-3.51±0.50(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|